Found: 38
Select item for more details and to access through your institution.
The Discovery of α‐Synuclein in Lewy Pathology of Parkinson's Disease: The Inspiration of a Revolution.
- Published in:
- Movement Disorders Clinical Practice, 2021, v. 8, n. 8, p. 1189, doi. 10.1002/mdc3.13312
- By:
- Publication type:
- Article
A proteomic analysis of pediatric seizure cases associated with astrocytic inclusions.
- Published in:
- Epilepsia (Series 4), 2012, v. 53, n. 3, p. e50, doi. 10.1111/j.1528-1167.2011.03369.x
- By:
- Publication type:
- Article
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
- Published in:
- Acta Neuropathologica Communications, 2017, v. 5, p. 1, doi. 10.1186/s40478-017-0416-x
- By:
- Publication type:
- Article
Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.852003
- By:
- Publication type:
- Article
Short-term deceleration capacity of heart rate: a sensitive marker of cardiac autonomic dysfunction in idiopathic Parkinson's disease.
- Published in:
- Clinical Autonomic Research, 2021, v. 31, n. 6, p. 729, doi. 10.1007/s10286-021-00815-4
- By:
- Publication type:
- Article
Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.
- Published in:
- Clinical Autonomic Research, 2019, v. 29, n. 6, p. 603, doi. 10.1007/s10286-019-00632-w
- By:
- Publication type:
- Article
RETRACTED ARTICLE: Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors.
- Published in:
- BMC Neuroscience, 2008, v. 9, n. 1, p. 1, doi. 10.1186/1471-2202-9-92
- By:
- Publication type:
- Article
Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Using artificial intelligence to identify anti‐hypertensives as possible disease modifying agents in Parkinson's disease.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 2, p. 201, doi. 10.1002/pds.5176
- By:
- Publication type:
- Article
Cell‐Specific Dysregulation of Iron and Oxygen Homeostasis as a Novel Pathophysiology in PSP.
- Published in:
- Annals of Neurology, 2023, v. 93, n. 3, p. 431, doi. 10.1002/ana.26540
- By:
- Publication type:
- Article
An AI-guided screen identifies probucol as an enhancer of mitophagy through modulation of lipid droplets.
- Published in:
- PLoS Biology, 2023, v. 21, n. 3, p. 1, doi. 10.1371/journal.pbio.3001977
- By:
- Publication type:
- Article
Tumor Necrosis Factor-α Underlies Loss of Cortical Dendritic Spine Density in a Mouse Model of Congestive Heart Failure.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Identifying drugs with disease‐modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 8, p. 864, doi. 10.1002/pds.5015
- By:
- Publication type:
- Article
The MonKEY to Unlocking the Pathogenesis of Progressive Supranuclear Palsy.
- Published in:
- Movement Disorders, 2023, v. 38, n. 6, p. 953, doi. 10.1002/mds.29404
- By:
- Publication type:
- Article
Epigenetic Clock Acceleration Is Linked to Age at Onset of Parkinson's Disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Combining Skin α‐Synuclein Real‐Time Quaking‐Induced Conversion and Circulating Neurofilament Light Chain to Distinguish Multiple System Atrophy and Parkinson's Disease.
- Published in:
- Movement Disorders, 2022, v. 37, n. 3, p. 648, doi. 10.1002/mds.28912
- By:
- Publication type:
- Article
Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's Disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Call the Plumber: Impaired Meningeal Lymphatic Drainage in Parkinson's Disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
α-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders.
- Published in:
- Acta Neuropathologica, 2022, v. 144, n. 2, p. 167, doi. 10.1007/s00401-022-02453-0
- By:
- Publication type:
- Article
Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy.
- Published in:
- Translational Neurodegeneration, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40035-022-00283-4
- By:
- Publication type:
- Article
Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities.
- Published in:
- Translational Neurodegeneration, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40035-019-0172-x
- By:
- Publication type:
- Article
Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice.
- Published in:
- Human Molecular Genetics, 2008, v. 17, n. 10, p. 1386, doi. 10.1093/hmg/ddn026
- By:
- Publication type:
- Article
Toward an animal model of Progressive Supranuclear Palsy.
- Published in:
- Frontiers in Neuroscience, 2024, p. 1, doi. 10.3389/fnins.2024.1433465
- By:
- Publication type:
- Article
Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Reply to: Gray et al.
- Published in:
- Movement Disorders, 2014, v. 29, n. 9, p. 1225, doi. 10.1002/mds.25941
- By:
- Publication type:
- Article
Novel transgenic technology reveals several molecular adaptations and potential therapeutic targets in the direct pathway in levodopa-induced dyskinesia.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Alimentary, my dear Watson? The challenges of enteric [alpha]-synuclein as a Parkinson's disease biomarker.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
- Published in:
- Movement Disorders, 2014, v. 29, n. 4, p. 444, doi. 10.1002/mds.25789
- By:
- Publication type:
- Article
Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Increased levels of 5-HT<sub>1A</sub> receptor binding in ventral visual pathways in Parkinson's disease.
- Published in:
- Movement Disorders, 2012, v. 27, n. 6, p. 735, doi. 10.1002/mds.24964
- By:
- Publication type:
- Article
Increased 5-HT<sub>2A</sub> receptors in the temporal cortex of parkinsonian patients with visual hallucinations.
- Published in:
- Movement Disorders, 2010, v. 25, n. 10, p. 1399, doi. 10.1002/mds.23083
- By:
- Publication type:
- Article
The nociceptin/orphanin FQ (NOP) receptor antagonist J-113397 enhances the effects of levodopa in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
- Published in:
- Movement Disorders, 2008, v. 23, n. 13, p. 1922, doi. 10.1002/mds.22086
- By:
- Publication type:
- Article
Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
- Published in:
- Movement Disorders, 2006, v. 21, n. 11, p. 1879, doi. 10.1002/mds.21073
- By:
- Publication type:
- Article
Histamine H3 receptor agonists reduce.
- Published in:
- Movement Disorders, 2006, v. 21, n. 6, p. 839, doi. 10.1002/mds.20828
- By:
- Publication type:
- Article
Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans.
- Published in:
- Molecular Neurodegeneration, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13024-021-00497-6
- By:
- Publication type:
- Article
Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans.
- Published in:
- Molecular Neurodegeneration, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13024-021-00497-6
- By:
- Publication type:
- Article
Retraction Note to: Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors.
- Published in:
- 2021
- By:
- Publication type:
- corrected article